Patents by Inventor Fabien Perugi

Fabien Perugi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBUNIT VACCINE FOR TREATMENT OR PREVENTION OF A RESPIRATORY TRACT INFECTION
    Publication number: 20240067681
    Abstract: The present invention relates to modified hMPV F proteins stabilized in the pre-fusion conformation as vaccine candidates.
    Type: Application
    Filed: October 24, 2023
    Publication date: February 29, 2024
    Applicant: Valneva SE
    Inventors: Fabien Perugi, Klaus Schwamborn, Wolfgang Schüler, Urban Lundberg, Andreas Meinke
  • A SUBUNIT VACCINE FOR TREATMENT OR PREVENTION OF A RESPIRATORY TRACT INFECTION
    Publication number: 20220185847
    Abstract: The present invention relates to modified metapneumovirus (hMPV) F proteins, stabilized in the pre-fusion conformation. It also relates to immunogenic compositions (vaccines) comprising these proteins for preventing and/or treating human subjects against respiratory tract infections.
    Type: Application
    Filed: May 19, 2020
    Publication date: June 16, 2022
    Applicant: Valneva SE
    Inventors: Fabien Perugi, Klaus Schwamborn, Wolfgang Schüler, Urban Lundberg, Andreas Meinke
  • METHOD FOR RESCUING AND PRODUCING A VIRUS IN AVIAN CELLS
    Publication number: 20210275662
    Abstract: The present invention relates to methods of rescue and/or propagation of paramyxovirus species, particularly wherein both rescue and propagation are carried out in the same cell type; i.e., without the use of helper cells for viral rescue. The paramyxoviruses produced by the disclosed methods may encompass wild-type viruses, chimeric viruses, recombinant viruses or engineered viral products such as virus like particles (VLP). Viruses and/or viral products produced in the method according to the current invention are suitable for medical or veterinary use in such applications as treating or preventing infectious diseases, particularly avian paramyxovirus and human respiratory virus infections, and cancer treatment.
    Type: Application
    Filed: July 15, 2019
    Publication date: September 9, 2021
    Applicant: Valneva SE
    Inventors: Luc Batard, Caroline Freslon-Evain, Fabien Perugi, Klaus Schwamborn